Wernly Bernhard, Lichtenauer Michael, Franz Marcus, Kabisch Bjoern, Muessig Johanna, Masyuk Maryna, Hoppe Uta C, Kelm Malte, Jung Christian
Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Salzburg Austria.
Clinic of Internal Medicine I, Department of Cardiology, Jena University Hospital, Jena, Germany.
PLoS One. 2017 Feb 2;12(2):e0170987. doi: 10.1371/journal.pone.0170987. eCollection 2017.
MELD-XI, an adapted version of Model for End-stage Liver Disease (MELD) score excluding INR, was reported to predict outcomes e.g. in patients with acute heart failure. We aimed to evaluate MELD-XI in critically ill patients admitted to an intensive care unit (ICU) for prognostic relevance.
A total of 4381 medical patients (66±14 years, 2862 male) admitted to a German ICU between 2004 and 2009 were included and retrospectively investigated. Admission diagnoses were e.g. myocardial infarction (n = 2034), sepsis (n = 694) and heart failure (n = 688). We divided our patients in two cohorts basing on their MELD-XI score and evaluated the MELD-XI score for its prognostic relevance regarding short-term and long-term survival. Optimal cut-offs were calculated by means of the Youden-Index.
Patients with a MELD-XI score >12 had pronounced laboratory signs of organ failure and more comorbidities. MELD-XI >12 was associated with an increase in short-term (27% vs 6%; HR 4.82, 95%CI 3.93-5.93; p<0.001) and long-term (HR 3.69, 95%CI 3.20-4.25; p<0.001) mortality. In a univariate Cox regression analysis for all patients MELD-XI was associated with increased long-term mortality (changes per score point: HR 1.06, 95%CI 1.05-1.07; p<0.001) and remained to be associated with increased mortality after correction in a multivariate regression analysis for renal failure, liver failure, lactate concentration, blood glucose concentration, oxygenation and white blood count (HR 1.04, 95%CI 1.03-1.06; p<0.001). Optimal cut-off for the overall cohort was 11 and varied remarkably depending on the admission diagnosis: myocardial infarction (9), pulmonary embolism (9), cardiopulmonary resuscitation (17) and pneumonia (17). We performed ROC-analysis and compared the AUC: SAPS2 (0.78, 95%CI 0.76-0.80; p<0.0001) and APACHE (0.76, 95%CI 0.74-0.78; p<0.003) score were superior to MELD-XI (0.71, 95%CI 0.68-0.73) for prediction of mortality.
The easily calculable MELD-XI score is a robust and reliable tool to predict both intra-ICU and long-term mortality in critically ill medical patients admitted to an ICU. Optimal cut-off values for MELD-XI scores seem to depend on the primary disease and need to be validated in future prospective studies. Compared to SAPS2 and APACHE score, MELD-XI lacks precision but might have comparable and even additive value, as it is easily available and independent of subjective values.
据报道,终末期肝病模型(MELD)评分的改良版MELD-XI可排除国际标准化比值(INR),用于预测急性心力衰竭等患者的预后。我们旨在评估MELD-XI在入住重症监护病房(ICU)的危重症患者中的预后相关性。
纳入2004年至2009年间入住德国一家ICU的4381例内科患者(66±14岁,男性2862例),并进行回顾性研究。入院诊断包括心肌梗死(n = 2034)、脓毒症(n = 694)和心力衰竭(n = 688)。我们根据患者的MELD-XI评分将其分为两个队列,并评估MELD-XI评分在短期和长期生存方面的预后相关性。通过约登指数计算最佳截断值。
MELD-XI评分>12的患者有明显的器官功能衰竭实验室指标和更多的合并症。MELD-XI>12与短期(27%对6%;风险比4.82,95%置信区间3.93 - 5.93;p<0.001)和长期(风险比3.69,95%置信区间3.20 - 4.25;p<0.001)死亡率增加相关。在对所有患者进行的单因素Cox回归分析中,MELD-XI与长期死亡率增加相关(每评分点变化:风险比1.06,95%置信区间1.05 - 1.07;p<0.001),在对肾衰竭、肝衰竭、乳酸浓度、血糖浓度、氧合和白细胞计数进行多因素回归分析校正后,仍与死亡率增加相关(风险比1.04,95%置信区间1.03 - 1.06;p<0.001)。整个队列的最佳截断值为11,且因入院诊断不同而有显著差异:心肌梗死(9)、肺栓塞(9)、心肺复苏(17)和肺炎(17)。我们进行了ROC分析并比较了曲线下面积(AUC):序贯器官衰竭评估(SOFA)评分(0.78,95%置信区间0.76 - 0.80;p<0.0001)和急性生理与慢性健康状况评分系统(APACHE)(0.76,95%置信区间0.74 - 0.78;p<0.003)在预测死亡率方面优于MELD-XI(0.71,95%置信区间0.68 - 0.73)。
易于计算的MELD-XI评分是预测入住ICU的危重症内科患者ICU内死亡率和长期死亡率的可靠工具。MELD-XI评分的最佳截断值似乎取决于原发性疾病,需要在未来的前瞻性研究中进行验证。与SOFA评分和APACHE评分相比,MELD-XI缺乏精确性,但可能具有可比甚至相加的价值,因为它易于获得且独立于主观值。